Followers | 199 |
Posts | 21795 |
Boards Moderated | 2 |
Alias Born | 11/07/2005 |
Thursday, June 22, 2017 9:53:03 AM
So no need to day trade down here as there is mad upside on this news. Based on 200 million shares now locked in cause no raise in autherized then .02 to .03 seems maybe even the LOW end of things, IMO.
**********
Updated: June 22, 2017
Ludlow Research Upgrades DTII to $0.03+ on Major Reduction of Debt
(NEW YORK)–The recent reduction of debt, in terms that are friendly to sharehodlers, has prompted Ludlow Research to issue Defense Technologies International Corp. (OTC:DTII), a developer of security technologies, and short term speculative target of $0.03 per share.
On June 13, 2017, the Company issued 1,751,824 preferred shares to two individuals in exchange for full payment of $175,182 of debt. Each Series A preferred share is convertible into 10 shares of DTII voting common stock, and carries voting rights on the basis of 100 votes per preferred share on any vote of common stockholders.
If fully converted that would come out to 17,518,240 common shares. So, for the debt holder to be made whole on their $175k debt DTII stock would have to be trading at a price of at least $0.01 to $0.02 per share, minimum.
Add in there is no raise in authorized to cover these shares, and any conversion as we confirmed would be into “restricted” common shares, then it seems likely these new preferred share holders are in DTII for the long-term, and most likely for prices much higher then $0.02 per share.
For this reason Ludlow Research has issued DTII a short-term ‘speculative valuation target of $0.02 to $0.03+ per share.
http://www.wallstreetnewscast.com/profile/dtii/
Remember what happened last time...this ran from .002 to like .04 in just a few days...LOAD UP KIDDIES!!!
Have a great low float, or killer chart to share with our group of traders?
Post it up on my new board!
Sweet Crude's - Low Float and Chart Plays (please join)
http://investorshub.advfn.com/boards/board.aspx?board_id=21852
Recent DTII News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 08:26:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/20/2023 10:23:35 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 12/15/2023 07:42:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/25/2023 08:12:07 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 09/15/2023 05:22:20 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 08/25/2023 09:10:05 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 08/15/2023 09:15:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 09:21:47 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 07/31/2023 06:45:49 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM